TABLET SHAPED
| Brand | Owner | Address | Description |
|---|---|---|---|
| FVG | Toyo Shinyaku Co., Ltd. | 19-27, Hakataekimae 2-chome, Hakata-ku Fukuoka-shi, Fukuoka 812-0011 Japan | Tablet-shaped, solid, powdery, granular, hard capsular, soft capsular, pasted, liquid and cookie-shaped processed foods mainly containing oligomeric proanthocyanidins extracted from pine bark, namely, soybeans, dried cabbage, fermented cabbage, raisins and dried prunes; tablet-shaped, solid, powdery, granular, hard capsular, soft capsular, pasted, liquid and cookie-shaped dietary supplements mainly containing oligomeric proanthocyanidins extracted from pine bark; tablet-shaped, solid, powdery, granular, hard capsular, soft capsular, pasted, liquid and cookie-shaped processed foods mainly containing polyphenol, namely, soybeans, dried cabbage, fermented cabbage, raisins and dried prunes; tablet-shaped, solid, powdery, granular, hard capsular, soft capsular, pasted, liquid and cookie-shaped dietary supplements mainly containing polyphenol;Pharmaceuticals mainly containing oligomeric proanthocyanidins extracted from pine bark, namely, pharmaceuticals for the treatment of disorders in the central nervous system, the peripheral nervous system, the respiratory organs, the digestive organs, the uro-genital and anal organs, and the epidermis, and for the treatment of rhinitic diseases, otitic diseases, hepatic diseases, diabetes, gout, allergic diseases, gynecological diseases and cardiovascular diseases; nutritional additives for medical use mainly containing oligomeric proanthocyanidins extracted from pine bark, namely, nutritional tonics; Pharmaceuticals mainly containing oligomeric proanthocyanidins extracted from pine bark, namely, tumor suppressing agents; Pharmaceuticals mainly containing oligomeric proanthocyanidins extracted from pine bark, namely, pharmaceuticals for treating physically-caused lesions, pharmaceuticals for treating chemically-caused disorders and for use as contraceptives, eye drops and solutions for contact lenses; Pharmaceuticals mainly containing oligomeric proanthocyanidins extracted from pine bark for use as dental treatments, hemostats, alexipharmics and anticoagulants; Pharmaceuticals mainly containing oligomeric proanthocyanidins extracted from pine bark for treating substance abuses and addictions; nutritional additives for food for medical use mainly containing oligomeric proanthocyanidins extracted from pine bark; dietary foods for medical purposes mainly containing oligomeric proanthocyanidins extracted from pine bark;Cosmetics mainly containing oligomeric proanthocyanidins extracted from pine bark, namely, face cream, body cream, eye cream, hair cream, face lotion, milky lotion for skin, anti-aging beauty sera for skin, whitening beauty sera for skin, oil-controlling beauty sera for skin, moisturizing beauty sera for skin, lifting beauty sera for skin, anti-wrinkle beauty sera for skin, facial cleansing foam, makeup removing cream; soaps and shampoos mainly containing oligomeric proanthocyanidins extracted from pine bark; toothpaste mainly containing oligomeric proanthocyanidins extracted from pine bark; mouthwash mainly containing oligomeric proanthocyanidins extracted from pine bark; perfumery mainly containing oligomeric proanthocyanidins extracted from pine bark; bath salts mainly containing oligomeric proanthocyanidins extracted from pine bark;Soft drinks mainly containing oligomeric proanthocyanidins extracted from pine bark; preparations for making soft drinks, namely, concentrates containing oligomeric proanthocyanidin extracted from pine bark, syrups containing oligomeric proanthocyanidin extracted from pine bark, powders containing oligomeric proanthocyanidin extracted from pine bark and granules containing oligomeric proanthocyanidin extracted from pine bark; fruit beverages mainly containing oligomeric proanthocyanidins extracted from pine bark; vegetable juices mainly containing oligomeric proanthocyanidins extracted from pine bark; whey-based beverages mainly containing oligomeric proanthocyanidins extracted from pine bark; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- A solid heparin tablet composition has a melting point of 25° C. or higher and is a continuous lipid component containing one or more polar lipids, one or more non-polar lipids, optionally one or several of water and mono- to trivalent alcohol in an amount of up to 15% by weight of the composition, and native heparin or fractionated heparin. Also described is a corresponding tablet, processes for production of the composition and the tablet, and a method of preventing or treating conditions amenable to preventive or therapeutic treatment by administration of the tablet.